Telomere crisis in kidney epithelial cells promotes the acquisition of a microRNA signature retrieved in aggressive renal cell carcinomas

Carcinogenesis

Volumn 34, Issue 5, 2013, Pages 1173-1180

  Castro Vega, Luis Jaime ^a,b   Jouravleva, Karina ^a,b   Liu, Win Yan ^a,b   Martinez, Carolina ^c   Gestraud, Pierre ^d,e   Hupé, Philippe ^a,d,e   Servant, Nicolas ^d,e   Albaud, Benoît ^a   Gentien, David ^a   Gad, Sophie ^f   Richard, Stéphane ^f   Bacchetti, Silvia ^g   Londoño Vallejo, Arturo ^a,b  

^a INSTITUT CURIE   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c PSL RESEARCH UNIVERSITY   (France)

^d INSERM U900   (France)

^e PSL RESEARCH UNIVERSITY   (France)

^f INSTITUT GUSTAVE ROUSSY   (France)

^g REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 200;

ARTICLE; CELL DIFFERENTIATION; CELL IMMORTALIZATION; CELL INVASION; CELL MIGRATION; CELL STRUCTURE; CHROMOSOMAL INSTABILITY; DNA DAMAGE; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; KIDNEY EPITHELIUM; METASTASIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TELOMERE; TELOMERE SHORTENING; TUMOR CELL; UPREGULATION;

CARCINOMA, RENAL CELL; CELL LINE, TUMOR; CHROMOSOMAL INSTABILITY; DNA DAMAGE; EPITHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; HEK293 CELLS; HUMANS; KIDNEY NEOPLASMS; MICRORNAS; TELOMERE; TRANSCRIPTION, GENETIC;

EID: 84877104492     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt029     Document Type: Article

References (42)

1. Romanov,S.R. et al. (2001) Normal human mammary epithelial cells spontaneously escape senescence and acquire genomic changes. Nature, 409, 633-637.
2. Meeker,A.K. et al. (2004) Telomere length abnormalities occur early in the initiation of epithelial carcinogenesis. Clin. Cancer Res., 10, 3317-3326.
3. DePinho,R.A. (2000) The age of cancer. Nature, 408, 248-254.
4. Lengauer,C. et al. (1998) Genetic instabilities in human cancers. Nature, 396, 643-649.
5. Campbell,P.J. et al. (2010) The patterns and dynamics of genomic instability in metastatic pancreatic cancer. Nature, 467, 1109-1113.
6. Rudolph,K.L. et al. (1999) Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell, 96, 701-712.
7. Rudolph,K.L. et al. (2001) Telomere dysfunction and evolution of intestinal carcinoma in mice and humans. Nat. Genet., 28, 155-159.
8. Artandi,S.E. et al. (2000) Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature, 406, 641-645.
9. Bojovic,B. et al. (2011) Telomere dysfunction promotes metastasis in a TERC null mouse model of head and neck cancer. Mol. Cancer Res., 9, 901-913.
10. O'Hagan,R.C. et al. (2002) Telomere dysfunction provokes regional amplification and deletion in cancer genomes. Cancer Cell, 2, 149-155.
11. Ding,Z. et al. (2012) Telomerase reactivation following telomere dysfunction yields murine prostate tumors with bone metastases. Cell, 148, 896-907.
12. La Rosa,P. et al. (2006) VAMP: visualization and analysis of array-CGH, transcriptome and other molecular profiles. Bioinformatics, 22, 2066-2073.
13. Neuvial,P. et al. (2006) Spatial normalization of array-CGH data. BMC Bioinformatics, 7, 264.
14. Hupe,P. et al. (2004) Analysis of array CGH data: from signal ratio to gain and loss of DNA regions. Bioinformatics, 20, 3413-3422.
15. Chen,C.J. et al. (2012) ncPRO-seq: a tool for annotation and profiling of ncRNAs in sRNA-seq data. Bioinformatics, 28, 3147-3149.
16. Langmead,B. et al. (2009) Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol., 10, R25.
17. Griffiths-Jones,S. et al. (2008) miRBase: tools for microRNA genomics. Nucleic Acids Res., 36, D154-D158.
18. Anders,S. et al. (2010) Differential expression analysis for sequence count data. Genome Biol., 11, R106.
19. Schmittgen,T.D. et al. (2008) Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc., 3, 1101-1108.
20. Vandesompele,J. et al. (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol., 3, RESEARCH0034.
21. Mestdagh,P. et al. (2009) A novel and universal method for microRNA RT-qPCR data normalization. Genome Biol., 10, R64.
22. Counter,C.M. et al. (1992) Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J., 11, 1921-1929.
23. der-Sarkissian,H. et al. (2004) The shortest telomeres drive karyotype evolution in transformed cells. Oncogene, 23, 1221-1228.
24. Calin,G.A. et al. (2004) Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc. Natl. Acad. Sci. U.S.A., 101, 2999-3004.
25. Zhang,X. et al. (2011) The ATM kinase induces microRNA biogenesis in the DNA damage response. Mol. Cell, 41, 371-383.
26. d'Adda di Fagagna,F. et al. (2003) A DNA damage checkpoint response in telomere-initiated senescence. Nature, 426, 194-198.
27. Reaper,P.M. et al. (2004) Activation of the DNA damage response by telomere attrition: a passage to cellular senescence. Cell Cycle, 3, 543-546.
28. de Lange,T. (2005) Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev., 19, 2100-2110.
29. van Steensel,B. et al. (1998) TRF2 protects human telomeres from end-toend fusions. Cell, 92, 401-413.
30. Gregory,P.A. et al. (2008) The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat. Cell Biol., 10, 593-601.
31. Park,S.M. et al. (2008) The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev., 22, 894-907.
32. Kalluri,R. et al. (2009) The basics of epithelial-mesenchymal transition. J. Clin. Invest., 119, 1420-1428.
33. Ivanova,L. et al. (2010) Ontogeny of CD24 in the human kidney. Kidney Int., 77, 1123-1131.
34. Redova,M. et al. (2011) MicroRNAs and their target gene networks in renal cell carcinoma. Biochem. Biophys. Res. Commun., 405, 153-156.
35. Heinzelmann,J. et al. (2011) Specific miRNA signatures are associated with metastasis and poor prognosis in clear cell renal cell carcinoma. World J. Urol., 29, 367-373.
36. Chen,M. et al. (2009) Genome-wide profiling of chromosomal alterations in renal cell carcinoma using high-density single nucleotide polymorphism arrays. Int. J. Cancer, 125, 2342-2348.
37. Wentzensen,I.M. et al. (2011) The association of telomere length and cancer: a meta-analysis. Cancer Epidemiol. Biomarkers Prev., 20, 1238-1250.
38. Saal,S. et al. (2009) MicroRNAs and the kidney: coming of age. Curr. Opin. Nephrol. Hypertens., 18, 317-323.
39. Chin,K. et al. (2004) In situ analyses of genome instability in breast cancer. Nat. Genet., 36, 984-988.
40. Husemann,Y. et al. (2008) Systemic spread is an early step in breast cancer. Cancer Cell, 13, 58-68.
41. Polyak,K. et al. (2009) Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat. Rev. Cancer, 9, 265-273.
42. Hahn,W.C. et al. (1999) Creation of human tumour cells with defined genetic elements. Nature, 400, 464-468.